DZ2110A1 - Compositions for inhibiting the aggregation of platelets. - Google Patents
Compositions for inhibiting the aggregation of platelets.Info
- Publication number
- DZ2110A1 DZ2110A1 DZ960154A DZ960154A DZ2110A1 DZ 2110 A1 DZ2110 A1 DZ 2110A1 DZ 960154 A DZ960154 A DZ 960154A DZ 960154 A DZ960154 A DZ 960154A DZ 2110 A1 DZ2110 A1 DZ 2110A1
- Authority
- DZ
- Algeria
- Prior art keywords
- platelets
- aggregation
- inhibiting
- compositions
- tonicity
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4465—Non condensed piperidines, e.g. piperocaine only substituted in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Composition for i.v. administration is new comprises: (a) a compound of formula (I) or its salt; (b) a citrate buffer; and (c) a tonicity-adjusting agent to make the formulation isotonic. In (I), R4 = aryl, 1-10C alkyl or 1-10C arylalkyl; R5 = CO-R8; R8 = OH or 1-10C alkyloxy; m = 2-6; and p = 0 or 1.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US590795P | 1995-10-27 | 1995-10-27 | |
| GBGB9603721.3A GB9603721D0 (en) | 1996-02-22 | 1996-02-22 | Composition for inhibiting platelet aggregation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DZ2110A1 true DZ2110A1 (en) | 2002-07-22 |
Family
ID=26308777
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DZ960154A DZ2110A1 (en) | 1995-10-27 | 1996-10-26 | Compositions for inhibiting the aggregation of platelets. |
Country Status (35)
| Country | Link |
|---|---|
| EP (1) | EP0859634B1 (en) |
| JP (1) | JP3452367B2 (en) |
| KR (1) | KR100362799B1 (en) |
| CN (1) | CN1158107C (en) |
| AT (1) | ATE213648T1 (en) |
| AU (1) | AU712755B2 (en) |
| BG (1) | BG63623B1 (en) |
| BR (1) | BR9610878A (en) |
| CA (1) | CA2234364C (en) |
| CO (1) | CO4770960A1 (en) |
| CY (1) | CY2292B1 (en) |
| CZ (1) | CZ290381B6 (en) |
| DE (1) | DE69619540T2 (en) |
| DK (1) | DK0859634T3 (en) |
| DZ (1) | DZ2110A1 (en) |
| EA (1) | EA000628B1 (en) |
| EE (1) | EE03518B1 (en) |
| ES (1) | ES2171749T3 (en) |
| HK (1) | HK1017846A1 (en) |
| HU (1) | HU228757B1 (en) |
| IL (1) | IL123790A (en) |
| IS (1) | IS1948B (en) |
| MX (1) | MX9803275A (en) |
| MY (1) | MY116837A (en) |
| NO (1) | NO324415B1 (en) |
| NZ (1) | NZ323134A (en) |
| PL (1) | PL185744B1 (en) |
| PT (1) | PT859634E (en) |
| SA (1) | SA96170527B1 (en) |
| SI (1) | SI0859634T1 (en) |
| SK (1) | SK282353B6 (en) |
| TR (1) | TR199800716T2 (en) |
| TW (1) | TW385248B (en) |
| UA (1) | UA45423C2 (en) |
| WO (1) | WO1997015328A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPQ633900A0 (en) | 2000-03-20 | 2000-04-15 | Jurox Pty Ltd | Anaesthetic composition |
| CN1322863C (en) * | 2004-10-29 | 2007-06-27 | 武汉远大制药集团股份有限公司 | Injectio for inhibiting platelet aggregation and its preparation process |
| CN100386079C (en) * | 2005-03-24 | 2008-05-07 | 武汉远大制药集团股份有限公司 | Injection use-powder ampoule for inhibiting thrombocyte agglutination and its preparation method |
| CN100367961C (en) * | 2005-09-30 | 2008-02-13 | 天津南开允公医药科技有限公司 | Tirofiban hydrochloride freeze-dried powder injecta and preparing method |
| CN102125519B (en) * | 2011-02-28 | 2012-07-11 | 正大青春宝药业有限公司 | Stable tirofiban hydrochloride injection solution and preparation method thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4931441A (en) * | 1988-11-09 | 1990-06-05 | Luitpold Pharmaceuticals, Inc. | Stabilized aqueous leucovorin calcium compositions |
| NZ239846A (en) * | 1990-09-27 | 1994-11-25 | Merck & Co Inc | Sulphonamide derivatives and pharmaceutical compositions thereof |
-
1996
- 1996-10-17 TW TW085112709A patent/TW385248B/en not_active IP Right Cessation
- 1996-10-22 MY MYPI96004366A patent/MY116837A/en unknown
- 1996-10-23 SI SI9630443T patent/SI0859634T1/en unknown
- 1996-10-23 NZ NZ323134A patent/NZ323134A/en not_active IP Right Cessation
- 1996-10-23 EE EE9800134A patent/EE03518B1/en not_active IP Right Cessation
- 1996-10-23 KR KR10-1998-0702957A patent/KR100362799B1/en not_active IP Right Cessation
- 1996-10-23 EA EA199800336A patent/EA000628B1/en not_active IP Right Cessation
- 1996-10-23 HU HU9902521A patent/HU228757B1/en unknown
- 1996-10-23 AT AT96940256T patent/ATE213648T1/en active
- 1996-10-23 TR TR1998/00716T patent/TR199800716T2/en unknown
- 1996-10-23 JP JP51683897A patent/JP3452367B2/en not_active Expired - Fee Related
- 1996-10-23 WO PCT/US1996/017193 patent/WO1997015328A1/en active IP Right Grant
- 1996-10-23 AU AU77189/96A patent/AU712755B2/en not_active Ceased
- 1996-10-23 ES ES96940256T patent/ES2171749T3/en not_active Expired - Lifetime
- 1996-10-23 EP EP96940256A patent/EP0859634B1/en not_active Expired - Lifetime
- 1996-10-23 DK DK96940256T patent/DK0859634T3/en active
- 1996-10-23 PT PT96940256T patent/PT859634E/en unknown
- 1996-10-23 IL IL12379096A patent/IL123790A/en not_active IP Right Cessation
- 1996-10-23 UA UA98042034A patent/UA45423C2/en unknown
- 1996-10-23 PL PL96326419A patent/PL185744B1/en not_active IP Right Cessation
- 1996-10-23 SK SK512-98A patent/SK282353B6/en not_active IP Right Cessation
- 1996-10-23 CN CNB961978775A patent/CN1158107C/en not_active Expired - Lifetime
- 1996-10-23 CA CA002234364A patent/CA2234364C/en not_active Expired - Fee Related
- 1996-10-23 CZ CZ19981278A patent/CZ290381B6/en not_active IP Right Cessation
- 1996-10-23 BR BR9610878A patent/BR9610878A/en not_active IP Right Cessation
- 1996-10-23 DE DE69619540T patent/DE69619540T2/en not_active Expired - Lifetime
- 1996-10-24 CO CO96056416A patent/CO4770960A1/en unknown
- 1996-10-26 DZ DZ960154A patent/DZ2110A1/en active
- 1996-12-25 SA SA96170527A patent/SA96170527B1/en unknown
-
1998
- 1998-03-24 IS IS4699A patent/IS1948B/en unknown
- 1998-04-24 BG BG102405A patent/BG63623B1/en unknown
- 1998-04-24 NO NO19981869A patent/NO324415B1/en not_active IP Right Cessation
- 1998-04-24 MX MX9803275A patent/MX9803275A/en unknown
-
1999
- 1999-05-17 HK HK99102186A patent/HK1017846A1/en not_active IP Right Cessation
-
2002
- 2002-08-23 CY CY0200051A patent/CY2292B1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1075197A1 (en) | New composition containing taxane derivatives as major component | |
| KR920008024A (en) | Quinoline derivatives | |
| IL114726A0 (en) | Noribogaine derivatives and pharmaceutical compositions containing the same | |
| EP0223515A3 (en) | Oral compositions comprising salicylamides and zinc salts for the synergistic inhibition of dental plaque | |
| ES482782A1 (en) | Imidazole derivatives | |
| ES429221A1 (en) | N-(1-({107 -phenyl-alkyl)-piperidyl-4)-N-({60 -pyridyl)-carboxylic acid amides and salts thereof | |
| DE3176274D1 (en) | New cephem compounds and processes for preparation thereof | |
| DZ2110A1 (en) | Compositions for inhibiting the aggregation of platelets. | |
| DE3362504D1 (en) | 1-carboxyalkanoylindoline-2-carboxylic-acid esters, their preparation, pharmaceutical compositions containing them, and their therapeutic use | |
| IE43139L (en) | Bis-biguanide compounds | |
| GB1161349A (en) | New Capillary Product | |
| HUP9800631A2 (en) | 4-aminotetrahydrobenzisoxazole or -isothiazole derivatives, pharmaceutical compositions containing them and their use for the preparation of pharmaceutical compositions | |
| ES8604118A1 (en) | Carbamyloxybenzhydrole derivatives, process for their preparation and pharmaceutical compositions containing them. | |
| NZ246598A (en) | Trazodone derivatives; compounds and preparation, pharmaceutical compositions; intermediate compounds | |
| GR3032519T3 (en) | Cyclohexane derivatives, processes for their preparation and their use as glucose-6-phosphatase inhibitors. | |
| GB1413454A (en) | 4-alkoxyalkyleneoxy-5-benzylpyrimidines their preparation and pharmaceutical compositions thereof | |
| ES8302719A1 (en) | New cephem compounds, processes for preparation thereof and pharmaceutical composition comprising the same. | |
| ES8507524A1 (en) | Tropone derivatives, processes for preparation thereof and pharmaceutical composition comprising the same. | |
| ES8300709A1 (en) | Heterocyclic compounds, compositions thereof, their preparation and use. | |
| KR950000638A (en) | 3,4-dihydroxychalcone derivative | |
| IL145076A0 (en) | Novel intermediate for the synthesis of prostaglandins | |
| GB1384441A (en) | Benzomorphan derivatives | |
| GB1414938A (en) | 6-aza-1,2-dihydro-3h-1,4-benzodiazepines | |
| GB1488826A (en) | Anti-snore composition |